Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Cardiac failure

Not recruiting

Registered drug

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Azilsartan Medoxomil

Contact Research Centre

Non-small cell lung cancer stage III+5

Not recruiting

Registered drug

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Ociperlimab

Contact Research Centre

Non-small cell lung cancer stage IV

Not recruiting

Registered drugNo placebo

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Brigatinib

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drugNo placebo

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:ALKYLATING AGENTS

Contact Research Centre

Squamous cell carcinoma of lung+3

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Uveitis

Not recruiting

Registered drugNo placebo

Study on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Richter's syndrome

Not recruiting

Registered drugNo placebo

Study of Mosunetuzumab and Drug Combination for Untreated Patients with Richter's Syndrome

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mosunetuzumab

Contact Research Centre

Find therapies in clinical trials near you – page 20

303 trials match your criteria

Pulmonary arterial hypertension

Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Cardiac failure

Study of XXB750 and Drug Combination for Patients with Heart Failure

Non-small cell lung cancer stage III+5

Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Non-small cell lung cancer stage IV

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Pulmonary arterial hypertension

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

Myelofibrosis

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Squamous cell carcinoma of lung+3

Study Comparing Subcutaneous and Intravenous Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Transitional cell carcinoma

Study Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes

Triple negative breast cancer

Study of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer

Hormone receptor positive HER2 negative breast cancer

Study on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy

Uveitis

Study on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety

Richter's syndrome

Study of Mosunetuzumab and Drug Combination for Untreated Patients with Richter's Syndrome

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.